These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7298924)

  • 41. Behavioral effects of tricyclic drugs in depressed inpatients.
    Lyons JS; Rosen AJ; Dysken MW
    J Consult Clin Psychol; 1985 Feb; 53(1):17-24. PubMed ID: 3980824
    [No Abstract]   [Full Text] [Related]  

  • 42. The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks.
    Rodenbeck A; Cohrs S; Jordan W; Huether G; Rüther E; Hajak G
    Psychopharmacology (Berl); 2003 Dec; 170(4):423-8. PubMed ID: 13680082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose escalation of doxepin for intractable pruritus.
    Beck KM; Yang EJ; Koo J
    J Am Acad Dermatol; 2018 Sep; 79(3):e37. PubMed ID: 30119870
    [No Abstract]   [Full Text] [Related]  

  • 44. High affinity binding of tricyclic antidepressants to histamine H1-receptors: fact and artifact.
    Taylor JE; Richelson E
    Eur J Pharmacol; 1980 Oct; 67(1):41-6. PubMed ID: 6106553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Mar; 13(3):161-218. PubMed ID: 321205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FPIN's clinical inquiries: Antidepressants for the treatment of insomnia in patients with depression.
    Clark MS; Smith PO; Jamieson B
    Am Fam Physician; 2011 Nov; 84(9):1-2. PubMed ID: 22164891
    [No Abstract]   [Full Text] [Related]  

  • 47. Tricyclic-induced seizures and absent ECT response.
    Curran S
    Br J Psychiatry; 1994 Mar; 164(3):421. PubMed ID: 8199804
    [No Abstract]   [Full Text] [Related]  

  • 48. Topical application of the tricyclic antidepressant doxepin can reduce dysuria and frequency.
    McCleane G
    Scand J Urol Nephrol; 2004; 38(1):88-9. PubMed ID: 15204434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical antidepressants: the new local anesthetics?
    Strümper D; Durieux ME
    Reg Anesth Pain Med; 2003; 28(4):268-70. PubMed ID: 12945018
    [No Abstract]   [Full Text] [Related]  

  • 50. Histamine H1 receptors in human brain labelled with [3H]doxepin.
    Kanba S; Richelson E
    Brain Res; 1984 Jun; 304(1):1-7. PubMed ID: 6146381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-dose doxepin for the treatment of insomnia: emerging data.
    Goforth HW
    Expert Opin Pharmacother; 2009 Jul; 10(10):1649-55. PubMed ID: 19496739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical application of doxepin hydrochloride can reduce the symptoms of complex regional pain syndrome: a case report.
    McCleane G
    Injury; 2002 Jan; 33(1):88-9. PubMed ID: 11879844
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants.
    Bagheri H; Picault P; Schmitt L; Houin G; Berlan M; Montastruc JL
    Br J Clin Pharmacol; 1994 Jan; 37(1):93-6. PubMed ID: 8148228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topically applied mesoridazine exhibits the strongest cutaneous analgesia and minimized skin disruption among tricyclic antidepressants: The skin absorption assessment.
    Liu KS; Chen YW; Aljuffali IA; Chang CW; Wang JJ; Fang JY
    Eur J Pharm Biopharm; 2016 Aug; 105():59-68. PubMed ID: 27260201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histamine in the rat brain: effect of acute and chronic treatment with tricyclic antidepressants and H1-antihistaminics.
    Nowak JZ; Zawilska J
    Pol J Pharmacol Pharm; 1985; 37(2):147-62. PubMed ID: 2413428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Agents with tricyclic structures for treating peptic ulcer disease.
    Berardi RR; Caplan NB
    Clin Pharm; 1983; 2(5):425-31. PubMed ID: 6354568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antipruritic and thermal sensation effects of hydrocortisone creams in human skin.
    Zhai H; Frisch S; Pelosi A; Neibart S; Maibach HI
    Skin Pharmacol Appl Skin Physiol; 2000; 13(6):352-7. PubMed ID: 11096377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histamine-1 receptor antagonism for treatment of insomnia.
    Vande Griend JP; Anderson SL
    J Am Pharm Assoc (2003); 2012; 52(6):e210-9. PubMed ID: 23229983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical amitriptyline in post-traumatic neuropathic pain.
    Liebregts R; Kopsky DJ; Hesselink JM
    J Pain Symptom Manage; 2011 Apr; 41(4):e6-7. PubMed ID: 21481735
    [No Abstract]   [Full Text] [Related]  

  • 60. [Double-blind comparative study on the effects of lofepramine and amitriptyline in depressive outpatients (author's transl)].
    Wright S; Herrmann L
    Arzneimittelforschung; 1976; 26(6):1167-9. PubMed ID: 786313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.